Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Eterna Therapeutics Inc. | Director | Common Stock | 266K | $660K | $2.48 | Dec 2, 2022 | By Pacific Premier Trust, Custodian, FBO Nicholas J. Singer |
Eterna Therapeutics Inc. | Director | Common Stock | 122K | $302K | $2.48 | Dec 2, 2022 | By Purchase Capital LLC |
Eterna Therapeutics Inc. | Director | Warrants (right to buy) | 425K | Dec 2, 2022 | By Pacific Premier Trust, Custodian, FBO Nicholas J. Singer | ||
OTR Acquisition Corp. | Chief Executive Officer, Director | Class B Common Stock | 422K | May 20, 2022 | Indirect | ||
Eterna Therapeutics Inc. | Director | Warrants (right to buy) | 142K | Dec 2, 2022 | By Purchase Capital LLC | ||
OTR Acquisition Corp. | Chief Executive Officer, Director | Class A Common Stock | 0 | May 20, 2022 | PC SPAC Holdings LLC | ||
OTR Acquisition Corp. | Chief Executive Officer, Director | Class B Common Stock | 0 | May 20, 2022 | PC SPAC Holdings LLC | ||
OTR Acquisition Corp. | Chief Executive Officer, Director | Warrants | 0 | May 20, 2022 | PC SPAC Holdings LLC |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ERNA | Eterna Therapeutics Inc. | Dec 2, 2022 | 4 | $1M | 4 | Dec 6, 2022 | Director |
ERNA | Brooklyn ImmunoTherapeutics, Inc. | Aug 1, 2022 | 2 | $0 | 4 | Aug 3, 2022 | Director |
ERNA | Brooklyn ImmunoTherapeutics, Inc. | Jun 5, 2022 | 0 | $0 | 3 | Jun 7, 2022 | Director |
OTRA | OTR Acquisition Corp. | May 20, 2022 | 5 | $0 | 4 | May 20, 2022 | Chief Executive Officer, Director |
OTRA | OTR Acquisition Corp. | May 6, 2022 | 2 | $0 | 4 | May 10, 2022 | Chief Executive Officer, Director, 10%+ Owner |